Gerardus Johannes Platenburg
CIK: 0002115507
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PRQR
ProQR Therapeutics N.V.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Platenburg Gerardus Johannes
Platenburg Gerardus Johannes (SEC CIK 0002115507) files insider reports with the SEC as Chief Scientific Officer of ProQR Therapeutics N.V. (PRQR).
Signal8 holds 1 ownership filing by Platenburg Gerardus Johannes, a Form 3, filed on Mar 18, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Platenburg Gerardus Johannes's filings is in LEIDEN.
Other insiders filing for ProQR Therapeutics N.V. (PRQR)
- de Boer Daniel Anton, Chief Executive Officer
- Filius Bart, Director
- Hinsch Gylvin Lykke, Director
- Valerio Domenico, Director
- Maier Martin Alexander, Director
- Lawton Alison Frances, Director